Differences in drug-induced place conditioning between BALB/c and C57BL/6 mice

Pharmacology Biochemistry and Behavior

Volumn 65, Issue 3, 2000, Pages 419-423

  Belzung, Catherine ^a   Barreau, Serge ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

Amphetamine; BALB c; C57BL 6; Cocaine; Conditioned place preference; Morphine

Indexed keywords

AMPHETAMINE; COCAINE; MORPHINE;

ARTICLE; AVERSION; BEHAVIOR; CATECHOLAMINERGIC SYSTEM; CONDITIONING; CONTROLLED STUDY; GENOTYPE; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD;

AMPHETAMINE; ANIMALS; COCAINE; CONDITIONING (PSYCHOLOGY); MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MORPHINE; SPECIES SPECIFICITY;

EID: 0033956501     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00212-9     Document Type: Article

References (42)

1. Ågmo A., Belzung C., Deloire X., Grassin M., Lewis S. Blockade of anxiolytic-like actions of chlordiazepoxide by naloxone in the elevated plus-maze. Comparisons between SWISS, C57BL/6 and BALB/c mice Psychobiology. 27:1999;105-113.
2. Bardo M.T., Donohew R.L., Harrington N.G. Psychobiology of novelty seeking and drug seeking behavior. Behav. Brain Res. 77:1996;23-43.
3. Belzung C., Ågmo A. Naloxone blocks anxiolytic effects in Swiss but not in BALB/c mice. Psychopharmacology (Berlin). 132:1997;195-201.
4. Belzung C., Berton F. Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety. Behav. Pharmacol. 8:1997;541-548.
5. Beuzen A., Belzung C. Link between emotional memory and anxiety states. A study by principal component analysis Physiol. Behav. 58:1995;111-118.
6. Brase D.A., Loh H.H., Way E.L. Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains. J. Pharmacol. Exp. Ther. 261:1977;368-374.
7. Cabib S., Puglisi-Allegra S., Genua C., Simon H., Le Moal M., Piazza P.V. Dose-dependent aversive and rewarding effects of amphetamine as revealed by a new place conditioning apparatus. Psychopharmacology (Berlin). 125:1996;92-96.
8. Castellano C. Effects of mescaline and amphetamine on simultaneous visual discrimination in two inbred strains of mice. Psychopharmacology (Berlin). 62:1979;35-40.
9. Cunningham C.L., Niehus D.R., Malott D.H., Prather L.K. Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology (Berlin). 107:1992;385-393.
10. Erb S.M., Parker L.A. Individual differences in novelty-induced activity do not predict strength of amphetamine-induced place conditioning. Pharmacol. Biochem. Behav. 48:1994;581-586.
11. Freed W.J., Crump S., Jeste D.V. Genetic effect of PCP-induced stimulation in recombinant inbred strains of mice. Pharmacol. Biochem. Behav. 21:1984;159-162.
12. Goeders N.E., Smith J.E. Cortical dopaminergic involvement in cocaine reinforcement. Science. 221:1983;773-775.
13. Griebel G., Belzung C., Misslin R., Vogel E. The free exploratory paradigm. An effective method for measuring neophobic behavior in mice and testing potential neophobia reducing drugs Behav. Pharmacol. 4:1993;637-644.
14. Henricks K.K., Miner L.L., Marley R.J. Differential cocaine sensitivity between two closely related substrains of C57BL mice. Psychopharmacology (Berlin). 132:1997;161-168.
15. Hervé D., Tassin J.P., Barthelemy C., Blanc G., Lavielle S., Glowinski J. Difference in the reactivity of the mesocortical dopaminergic neurons to stress in the BALB/c and the C57BL/6 mice. Life Sci. 25:1979;1659-1664.
16. Hoebel B.G., Monaco A.P., Hernandez L., Aulisi E.F., Stanley B.G., Lenard L. Self-injection of amphetamine directly into the brain. Psychopharmacology (Berlin). 81:1983;158-163.
17. Jeste D.V., Stoff D.M., Rawlings R., Wyatt R.J. Pharmacogenetics of phenylethylamine. Determination of heritability and genetic transmission of locomotor effects in recombinant inbred strains of mice Psychopharmacology (Berlin). 84:1984;537-540.
18. Kitahana K., Valatx J.L. Strain difference in amphetamine sensitivity in mice. I. A diallel analysis of an open field activity. Psychopharmacology (Berlin). 66:1979;291-295.
19. Klebaur J.E., Bardo M.T. Individual differences in novelty seeking on the playground maze predict amphetamine conditioned place preference. Pharmacol. Biochem. Behav. 63:1999;131-136.
20. Koob G.F., Goeders N.E. Neuroanatomical substrates of drug self administration. Liebman J.M., Cooper S.J. The neuropharmacological basis of reward. 1989;214-263 Clarendon, Oxford.
21. Loh E.A., Roberts D.C.S. Break-points on a progressive ratio schedule reinforced by intravenous cocaine increase following depletion of forebrain serotonin. Psychopharmacology (Berlin). 101:1990;262-266.
22. 1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmacol. Biochem. Behav. 45:1993;239-242.
23. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dollé P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene. Nature. 383:1996;819-823.
24. Muraki T., Oike N., Shibata Y., Nomoto T. Analgesic effect of μ- and κ-opioid agonists in beige and CXBK mice. J. Pharmacol. Pharmacol. 43:1991;210-212.
25. Oliverio A., Eleftheriou B.E., Bailey D.W. Exploratory activity. Genetic analysis of its modiication by scopolamine and amphetamine Physiol. Behav. 10:1973;893-899.
26. Philipps A.G., Broekkamp C.L., Fibiger H.C. Strategies for studying the neurochemical substrates of drug reinforcement in rodents. Prog. Neuropsychol. Biol. Psychol. 7:1983;585-590.
27. Piazza P.V., Deminière J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
28. Piazza P.V., Deminière J.M., Maccari S., Mormède P., Le Moal M., Simon H. Individual reactivity to novelty predicts probability of amphetamine self-administration. Behav. Pharmacol. 1:1990;339-345.
29. Piazza P.V., Rouge-Pont R., Deminière J.M., Kharoubi M., Le Moal M., Simon H. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 567:1991;169-174.
30. Reith M.E.A., Sershen H., Vadasz C., Lajtha A. Strain differences in opiate receptors in mouse brain. Eur. J. Pharmacol. 74:1981;377-380.
31. Roberts D.C.S., Koob G.F. Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol. Biochem. Behav. 17:1982;901-904.
32. Schechter M.D., Calcagnetti D.J. Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991. Neurosci. Biobehav. Rev. 17:1993;21-41.
33. Seale T.W. Genetic differences in response to cocaine and stimulant drugs. Crabbe J.C., Harris J., Harris R.A. The genetic basis of alcohol and drug actions. 1991;Plenum Press, New York.
34. Seale T.W., Carney J.M. Genetic determinants of susceptibility to the rewarding and other behavioral actions of cocaine. J. Addict. Res. 10:1991;141-162.
35. Semenova S., Kuzmin A., Zvartau E. Strain differences in the analgesic and reinforcing action of morphine in mice. Pharmacol. Biochem. Behav. 50:1995;17-21.
36. Shuster L. Genetic analysis of morphine effects. activity, analgesia, tolerance and sensitization Eleftheriou B.E. Pharmacogenetics. 1975;Plenum Press, New York.
37. Shuster L., Webster G.W., Yu G., Eleftheriou B.E. A genetic analysis of the response to morphine in mice. Analgesia and running Psychopharmacologia. 42:1975;249-254.
38. Takemori A.E., Ho B.Y., Naeseth J.S., Porthogese P.S. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246:1998;255-258.
39. Vaccarino A.L., Tasker R.A.R., Melzack R. Systemic administration of naloxone produces analgesia in BALB/c mice. Neurosci. Lett. 84:1988;103-107.
40. Vaccarino A.L., Tasker R.A.R., Melzack R. Analgesia produced by normal doses of opiate antagonists alone or in combination with morphine. Pain. 36:1989;103-107.
41. Vaccarino A.L., Palmondo H., Melzack R. Analgesic and aversive effects of naloxone in BALB/c mice. Exp. Neurol. 117:1992;216-218.
42. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.